At present, there is a lack of effective treatments that target the causes of chronic obstructive pulmonary disease (COPD). Scientists of the Comprehensive Pneumology Center (CPC) at Helmholtz Zentrum München are therefore investigating the molecular causes of COPD in order to intervene specifically. A recently published study in the journal Oncotarget is a contribution to understanding the underlying causes of COPD, especially in the elderly population.
Inflammatory processes in lung tissue play a crucial role in the development of COPD. The main cause is assumed to be a reaction of lung tissue to chronic exposure to toxic gases or particles such as from cigarette smoke.
Picture: Dr. Ali Önder Yildirim and Dr. Gerrit John-Schuster
This results in excessive mucus production, cough and remodeling processes in the airways as well as the loss of alveoli, which are therefore no longer available for gas exchange. Increased activation of the immune system appear to be involved in these processes because the immune cell count in the lungs of COPD patients is significantly elevated.
Furthermore, premature aging of the lung cells is considered a factor favoring the development of COPD. To investigate this further, the research team led by Dr. Ali Önder Yildirim, Dr. Gerrit John-Schuster and Prof. Dr. Oliver Eickelberg at the CPC studied the influence of cells of the immune system on the development of COPD.
They demonstrated in an animal model that there is an association between advancing age and increased inflammation processes, especially if the lung is additionally exposed to cigarette smoke. “Our results show that age-related inflammatory changes play an important role in accelerated COPD development,” said first author John-Schuster.
“The current scientific consensus is that both aging and cigarette smoke facilitate the development of COPD. However, the mechanisms that lead to this remain unclear,” said study leader Yildirim. “We have shown for the first time that the immune response, especially in the aged lung, plays an essential role in the pathogenesis of the disease. This provides us with new directions for the development of innovative approaches to treatment.”
John-Schuster, G. et al. (2015). Inflammaging increases susceptibility to cigarette smoke-induced COPD, Oncotarget, 5
As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,300 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 37,000 staff members.
The Comprehensive Pneumology Center (CPC) is a joint research project of the Helmholtz Zentrum München, the Ludwig-Maximilians-Universität Clinic Complex and the Asklepios Fachkliniken München-Gauting. The CPC's objective is to conduct research on chronic lung diseases in order to develop new diagnosis and therapy strategies. The CPC maintains a focus on experimental pneumology with the investigation of cellular, molecular and immunological mechanisms involved in lung diseases. The CPC is a site of the Deutsches Zentrum für Lungenforschung (DZL).
Contact for the media:
Department of Communication, Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, 85764 Neuherberg - Phone: +49-(0)89-3187-2238 - Fax: +49 89-3187-3324 - Email: email@example.com
Scientific contact at Helmholtz Zentrum München:
Dr. Ali Önder Yildirim, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Institut für Lungenbiologie, Comprehensive Pneumology Center - Email: firstname.lastname@example.org
Location Neuherberg: Ingolstädter Landstr. 1, 85764 Neuherberg, Phone: +49-89-3187-4037
http://www.helmholtz-muenchen.de/en/news/latest-news/press-information-news/article/27059/index.html - Link to the press release
http://www.helmholtz-muenchen.de/en/index.html - Website Helmholtz Zentrum München
http://www.helmholtz-muenchen.de/ilbd/index.html - Website Institute of Lung Biology and Disease
Kommunikation | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Power and Electrical Engineering
05.12.2016 | Materials Sciences
05.12.2016 | Power and Electrical Engineering